Tue, Oct 21, 2014, 4:13 AM EDT - U.S. Markets open in 5 hrs 17 mins

Recent

% | $
Quotes you view appear here for quick access.

Intercept Pharmaceuticals, Inc. Message Board

  • usenatgas usenatgas Mar 18, 2014 7:35 AM Flag

    Motley Fool has a good article/comment out on ICPT 13 hrs ago as follows:

    "an absolute mound of data to take in during a single day and is a reason why I'm not shocked that Intercept's share price was all over the map today. What's really important here is that OCA looks great as a potential new therapy for primary bilary cirrhosis, and the concerns about increased lipid levels in its NASH trial appear to be statistically insignificant relative to the placebo group. While I would urge investors to be cautious given that with Intercept's share price has risen so much already, this update would suggest that OCA remains on track to possibly become a blockbuster therapy."
    I think the price targets recently given as $700 to $800 are reasonable.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Don't forget, you could be paid to write crap for MF. Why anyone wastes their time with them or all the other "FOOLS" is beyond me. Everyones got an opinion. Here's mine. BUY ICPT.

      Sentiment: Strong Buy

    • b.coogan@att.net b.coogan Mar 18, 2014 7:53 AM Flag

      consider the source of this article-----just pure babble with no direction like-When is product launch, what is 1st thru 5th year pro-forma's, earning expectation----just standard SOP's to use to judge if this company is worth 17 billion at $ 700 per share or 700 million----more than likely 700 million and that is a stretch

      motley fool are poor stewards of information they throw it around like a Navy cook tosses chili

      Sentiment: Strong Sell

 
ICPT
231.33+6.88(+3.07%)Oct 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NasdaqGSMon, Oct 20, 2014 4:00 PM EDT
TOTAL S.A.
NYSEMon, Oct 20, 2014 4:03 PM EDT